Edwards Lifesciences to Present at the Morgan Stanley 3rd Annual Healthcare Unplugged Conference IRVINE, Calif., May 2 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), the world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Morgan Stanley 3rd Annual Healthcare Unplugged Conference at the Mandarin Oriental Miami Hotel on May 5, 2005. Stuart L. Foster, Edwards Lifesciences' corporate vice president, Technology and Discovery, will speak to the attendees of the conference at 8:00 a.m. EDT. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences' investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards' investor relations website in the News and Events section. About Edwards Lifesciences Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT, and Swan-Ganz. Additional company information can be found at http://www.edwards.com/. Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office. DATASOURCE: Edwards Lifesciences CONTACT: Investors, David K. Erickson, +1-949-250-6826, or Media, Barry R. Liden, +1-949-250-5070, both of Edwards Lifesciences Web site: http://www.edwards.com/

Copyright